Ceftriaxone Pediatric Dose — Antimicrobial Reference
Ceftriaxone is a third-generation cephalosporin antibiotic that exerts bactericidal activity by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins. It offers broad-spectrum coverage against gram-positive and gram-negative organisms, including Streptococcus pneumoniae, Neisseria meningitidis, and many Enterobacteriaceae. In pediatric practice, ceftriaxone is widely used for the treatment of serious bacterial infections including community-acquired pneumonia, urinary tract infections, sepsis, and bacterial meningitis.
Pediatric Dosing
- Standard dose: 50 mg/kg IV once every 24 hours
- Adult dose equivalent: 2 g IV every 24 hours
- Adult meningitis dose: 2 g IV every 12 hours
For a 20 kg child: 20 × 50 mg/kg = 1,000 mg (1 g) IV every 24 hours. For a 10 kg child: 10 × 50 mg/kg = 500 mg IV every 24 hours. Consult institutional protocol for weight-based meningitis dosing frequency adjustments in pediatric patients, as higher or more frequent dosing may be used per local guidelines.
Indications and Clinical Context
Ceftriaxone is indicated for a broad range of pediatric bacterial infections, including community-acquired pneumonia, pyelonephritis, skin and soft tissue infections, septic arthritis, and bacteremia. Its once-daily dosing convenience makes it particularly practical in both inpatient and outpatient parenteral antibiotic therapy (OPAT) settings. Empiric use is supported by PALS and Pediatric Infectious Disease Society guidelines for sepsis and other serious infections requiring gram-negative coverage.
For bacterial meningitis in adults, the standard regimen is 2 g IV every 12 hours to achieve adequate CNS penetration. Pediatric meningitis dosing frequency and total daily dose should be confirmed with institutional or specialist guidance, as dose intensification is often employed to optimize CSF drug levels against susceptible pathogens such as S. pneumoniae and N. meningitidis.
Administration and Monitoring
Ceftriaxone is administered intravenously and may be given as a slow IV push or infused over 30 minutes; extended infusion over 30–60 minutes is preferred for serious infections to optimize pharmacodynamic exposure. It should not be co-administered or mixed with calcium-containing IV solutions (including Ringer’s lactate) due to the risk of precipitation, particularly in neonates. Use in neonates requires caution and specialist input given this interaction risk.
- Monitor for hypersensitivity reactions, particularly in patients with penicillin allergy (cross-reactivity is low but possible)
- Monitor renal and hepatic function with prolonged courses
- Ceftriaxone may cause biliary sludging with extended use
- Consult institutional protocol for maximum single-dose caps and meningitis-specific regimens
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.